Theresa Manriquez, PA
Medical · Austin, TXNPI 1578170791
Payments from drug & device makers
Across 649 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$865
- Lilly USA, LLC$698
- QOL Medical, LLC$649
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 143 | $3,055 |
| Takeda Pharmaceuticals U.S.A., Inc. | 58 | $1,387 |
| Johnson & Johnson(2 entities) | 58 | $1,063 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 81 | $865 |
| Lilly USA, LLC | 25 | $698 |
| QOL Medical, LLC | 28 | $649 |
| Ardelyx, Inc. | 34 | $624 |
| Sanofi | 20 | $542 |
| Bristol Myers Squibb | 26 | $474 |
| Aimmune Therapeutics, Inc. | 34 | $430 |
| Janssen Scientific Affairs, LLC | 5 | $354 |
| Antares Pharma, Inc. | 16 | $337 |
| Celltrion USA Inc. | 20 | $313 |
| Gilead | 11 | $263 |
| Intercept Pharmaceuticals, Inc. | 16 | $231 |
| Madrigal Pharmaceuticals | 10 | $199 |
| Pfizer | 13 | $184 |
| Ipsen Biopharmaceuticals, Inc | 8 | $171 |
| Merck | 6 | $159 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
| E.r. Squibb & Sons, L.L.C. | 2 | $114 |
| Amgen | 5 | $109 |
| Clarus Therapeutics Inc. | 4 | $89 |
| Nestle Healthcare Nutrition Inc. | 5 | $80 |
| Ferring Pharmaceuticals Inc. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Braintree Laboratories, Inc. | 4 | $62 |
| Organon | 3 | $44 |
| Redhill Biopharma Inc. | 2 | $28 |
| Ironwood Pharmaceuticals, Inc | 1 | $26 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| Vivus LLC | 1 | $18 |
How this compares
$12,874 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Austin
- Isabell BacotAustin$65K
- Lindsay ReckAustin$18K
- Amela PettyAustin$16K
- Jeri BelyeaAustin$14K
- Mikel ZamoraAustin$13K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.